✦ LIBER ✦

Changes in plasma mevalonate predict responsiveness to HMG CoA reductase inhibitors

✍ Scribed by R.P. Naoumova; D. Marais; W. Erkelens; N.B. Rendell; G.W. Taylor; G.R. Thompson

Book ID: 118324436
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 125 KB
Volume: 103
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(93)90280-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of plasma mevalonate to monitor HMG

Use of plasma mevalonate to monitor HMG CoA reductase inhibition

✍ G.R. Thompson; V. Maher; A. Pappu; D.R. Illingworth 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Plasma mevalonic acid, an index of chole

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia

✍ R.P. Naoumova; A.D. Marais; J. Mountney; J.C. Firth; N.B. Rendell; G.W. Taylor; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 967 KB

Genetic polymorphisms: importance for re

Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors

✍ Anke-Hilse Maitland-van der Zee; Olaf H. Klungel; Bruno H.Ch. Stricker; W.M. Mon 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Immune responses to HMG-CoA reductase in

Immune responses to HMG-CoA reductase inhibitors in patients with abnormal lipid level

✍ Bui, Minh N.; Caulfield, Michael T.; Katz, Paul; Cannon, Richard O.; Rackley, Ch 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Relationship between mevalonate pathway

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

✍ Alberto Corsini; Maria Mazzotti; Marco Raiteri; Maurizio R. Soma; Giulio Gabbian 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 869 KB

Robotic inhibition assay for determinati

Robotic inhibition assay for determination of HMG-CoA reductase inhibitors in human plasma

✍ Wei Fang; Lida Liu; John Y.-K. Hsieh; Jamie Zhao; Bogdan K. Matuszewski; John D. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB

## Abstract The cholesterol‐lowering drug simvastatin (SIMV, Zocor^®^) reduced heart attacks by 42% in patients who had high cholesterol levels and suffered from heart disease. Upon oral administration, SIMV is quickly hydrolyzed to its β‐hydroxyacid and other acid metabolites, which are potent inh